Cargando…

The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge

BACKGROUND: Interleukin 13 (IL13) is a T-helper type 2 (Th2) cytokine associated with inflammation and pathology in allergic diseases such as bronchial asthma. We have shown that treatment with lebrikizumab, an anti-IL13 monoclonal antibody, significantly improves prebronchodilator forced expiratory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheerens, H, Arron, J R, Zheng, Y, Putnam, W S, Erickson, R W, Choy, D F, Harris, J M, Lee, J, Jarjour, N N, Matthews, J G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204278/ https://www.ncbi.nlm.nih.gov/pubmed/24131304 http://dx.doi.org/10.1111/cea.12220

Ejemplares similares

Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)
por: Szefler, Stanley J., et al.
Publicado: (2022)

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
por: Hanania, Nicola A, et al.
Publicado: (2015)

Lebrikizumab in the personalized management of asthma
por: Thomson, Neil C, et al.
Publicado: (2012)

A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
por: Austin, Cary D., et al.
Publicado: (2020)

Profile of lebrikizumab and its potential in the treatment of asthma
por: Maselli, Diego Jose, et al.
Publicado: (2015)

OX40L blockade and allergen-induced airway responses in subjects with mild asthma
por: Gauvreau, G M, et al.
Publicado: (2014)

Segmental Bronchial Allergen Challenge Elicits Distinct Metabolic Phenotypes in Allergic Asthma
por: Zhu, Yanlong, et al.
Publicado: (2022)

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
por: Okragly, Angela J., et al.
Publicado: (2023)

Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis
por: Loh, Tiffany Y, et al.
Publicado: (2020)

Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date
por: Labib, Angelina, et al.
Publicado: (2022)

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
por: Bernardo, Diana, et al.
Publicado: (2023)

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma
por: Nakamura, Yutaka, et al.
Publicado: (2017)

Seasonal variability of lung function and Asthma Quality of Life Questionnaire Scores in adults with uncontrolled asthma
por: Bauer, Rebecca N, et al.
Publicado: (2019)

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma
por: Gauvreau, Gail M., et al.
Publicado: (2023)

The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma
por: Leaker, Brian R, et al.
Publicado: (2014)

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
por: Stein Gold, Linda, et al.
Publicado: (2023)

Transcriptional changes in alveolar macrophages from adults with asthma after allergen challenge
por: Yang, Jack, et al.
Publicado: (2021)

The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
por: Singh, Dave, et al.
Publicado: (2010)

Associations between sensitization to perennial/seasonal allergens and childhood asthma
por: Kuzdak, M., et al.
Publicado: (2018)

Fishing for Allergens: Bloodworm-Induced Asthma
por: Wu, Keith CP, et al.
Publicado: (2005)

The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
por: Bashrahil, Bader, et al.
Publicado: (2023)

Allergens, germs and asthma
por: Scadding, Glenis Kathleen
Publicado: (2015)

Allergen Immunotherapy in Asthma
por: Nakagome, Kazuyuki, et al.
Publicado: (2021)

The effect of mite allergen-impermeable covers in adult asthma: The SMAC study()
por: Woodcock, A., et al.
Publicado: (2003)

Identification of Genes Expressed by Human Airway Eosinophils after an In Vivo Allergen Challenge
por: Esnault, Stephane, et al.
Publicado: (2013)

Assessment of Peripheral Airway Function following Chronic Allergen Challenge in a Sheep Model of Asthma
por: Van der Velden, Joanne, et al.
Publicado: (2011)

The relevance of allergen exposure to the development of asthma in childhood()()()
por: Platts-Mills, Thomas A.E., et al.
Publicado: (2000)

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere)
por: Simpson, Eric L., et al.
Publicado: (2023)

Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014)

Allergen Avoidance in Allergic Asthma
por: Cipriani, Francesca, et al.
Publicado: (2017)

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study
por: Paller, Amy S., et al.
Publicado: (2023)

A whole genome sequencing study of moderate to severe asthma identifies a lung function locus associated with asthma risk
por: Chang, Diana, et al.
Publicado: (2022)

Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthma
por: Narala, Venkata R, et al.
Publicado: (2007)

Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma
por: Rousseau, Marie-Claire, et al.
Publicado: (2011)

Chronic mild prenatal stress exacerbates the allergen-induced airway inflammation in rats.
por: Nogueira, P J, et al.
Publicado: (1999)

Failure of introduction of food allergens after negative oral food challenge tests in children
por: van der Valk, J. P. M., et al.
Publicado: (2015)

Environmental tobacco smoke, indoor allergens, and childhood asthma.
por: Gold, D R
Publicado: (2000)

Swimming in Allergens?: Pool Use and Asthma
por: Spivey, Angela
Publicado: (2006)

Virus/Allergen Interactions and Exacerbations of Asthma
por: Kloepfer, Kirsten M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4q90hda8235k50t2pq7rg3eaou